- Home
- CCU vs ARQT Comparison
CCU vs ARQT Comparison
Compare CCU & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCU
- ARQT
- Stock Information
- Founded
- CCU 1850
- ARQT 2016
- Country
- CCU Chile
- ARQT United States
- Employees
- CCU N/A
- ARQT N/A
- Industry
- CCU Beverages (Production/Distribution)
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- CCU Consumer Staples
- ARQT Health Care
- Exchange
- CCU Nasdaq
- ARQT Nasdaq
- Market Cap
- CCU 2.2B
- ARQT 2.1B
- IPO Year
- CCU 1992
- ARQT 2020
- Fundamental
- Price
- CCU $12.92
- ARQT $24.76
- Analyst Decision
- CCU Strong Sell
- ARQT Strong Buy
- Analyst Count
- CCU 1
- ARQT 7
- Target Price
- CCU $10.00
- ARQT $22.17
- AVG Volume (30 Days)
- CCU 122.1K
- ARQT 2.5M
- Earning Date
- CCU 11-05-2025
- ARQT 10-28-2025
- Dividend Yield
- CCU 2.35%
- ARQT N/A
- EPS Growth
- CCU 38.53
- ARQT N/A
- EPS
- CCU 0.44
- ARQT N/A
- Revenue
- CCU $3,254,866,554.00
- ARQT $317,929,000.00
- Revenue This Year
- CCU $7.11
- ARQT $73.37
- Revenue Next Year
- CCU $4.64
- ARQT $31.36
- P/E Ratio
- CCU $14.58
- ARQT N/A
- Revenue Growth
- CCU 19.82
- ARQT 129.21
- 52 Week Low
- CCU $10.65
- ARQT $8.29
- 52 Week High
- CCU $15.75
- ARQT $27.08
- Technical
- Relative Strength Index (RSI)
- CCU 62.00
- ARQT 68.34
- Support Level
- CCU $12.64
- ARQT $19.60
- Resistance Level
- CCU $12.94
- ARQT $27.08
- Average True Range (ATR)
- CCU 0.24
- ARQT 1.32
- MACD
- CCU 0.06
- ARQT 0.38
- Stochastic Oscillator
- CCU 78.41
- ARQT 68.92
About CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.